# Beta lactam compounds, intermediates thereof, their use in preparing beta lactams having a diketopiperazine group.

## Abstract
Process for preparation of 6 7 alpha substituted beta lactams having a diketopiperazine group in the side chain, which comprises ring closure of a compound of partial structure CHEM R alkylthio, arythio, methoxy, hydroxymethyl amino or formamido.

## Claims
Claims 1. A compound having the partial structure II EMI66.1 wherein R represents C16 alkylthio, arylthio, methoxy, hydroxymethyl, amino or formamido R1 represents hydrocarbon or heterocyclyl R2 and R3 are the same or different and each represents hydrogen, optionally substituted C16 alkyl, halogen, aryl, amino, hydroxy or C1 6 alkoxy or R2 and R3 form the residue of a 5 or 6 membered carbocyclic or heterocyclic ring R4 represents hydrogen, or hydrocarbon and R5 represents hydrogen or a group which allows the Co2R5 group to effect N acylation. 2. A compound of formula IV EMI67.1 wherein R represents C1 6 alkylthio, arylthio, methoxy, hydroxymethyl, amino or formamido Y representsEMI67.2 wherein n is zero, 1 or 2 and Z represents hydrogen,halogen, or an organic group such as C1 4 alkoxy, CH2Q or CH CH Q wherein Q represents hydrogen, halogen, hydroxy, mercapto, cyano, carboxy, carboxylic ester, carbamoyloxy, C1 4 alkyloxy, acyloxy, aryl, a heterocyclyl group bonded via carbon, a heterocyclylthio group or a nitrogen containing heterocyclic group bonded via nitrogen R1 represents hydrocarbon or heterocyclyl R2 and R3 are the same or different and each represents hydrogen, optionally substituted C16 alkyl, halogen, aryl, amino, hydroxy or C16 alkoxy or R2 and R3 form the residue of a 5 or 6 membered carbocyclic or heterocyclic ring R4 represents hydrogen, or hydrocarbon Rx is hydrogen or a carboxyl blocking group and R5 represents hydrogen or a group which allows the C02R5 group to effect N acylation. 3. A compound as claimed in claim 2 in which Y is S C CH3 2 or S CH2 CZ where Z is as defined in respect of formula IV . 4. A compound as claimed in claim 2 or claim 3 in which R is formamido and R1 is 3,4 dihydroxyphenyl, 3, 4 diacetoxyphenyl or 3,4 dibenzyloxycarbonyloxy phenyl. 5. A process for the preparation of a compound as claimed in claim 1 which comprises reacting a compound having the partial structure V EMI69.1 wherein R, R1, R2, R3 and R4 are as defined with respect to formula II with a reactive N acylating derivative of an acid of formula VI R502C.Co2H VI wherein R5 is as defined with respect to formula II . 6. A process for the preparation of a compound as claimed in claim 2 which comprises reacting a compound of formula Va EMI69.2 wherein R, R1, R2, R3, R4, Rx and Y are as defined with respect to formula IV with a reactive N acylating derivative of an acid of formula VI R502C.Co2H VI wherein R5 is as defined with respect to formula IV . 7. A process for the preparation of a compound as claimed in claim 1 which comprises reacting a compound of formula VII EMI70.1 wherein R and R1 are as defined with respect to formulaII with a compound of formula IX EMI70.2 wherein R2, R3, R4, R5 are as defined with respect to formula II, and one of X1 and X2 represents amino1 and the other represents an N acylating derivative of a carbamic acid group, NH.CO2H. 8. A process for the preparation of a compound as claimed in claim 2 which comprises reacting a compound of formula VIIa EMI71.1 wherein R, R1, Rx and Y are as defined with respect to formulaCiv with a compound of formula IX EMI71.2 wherein R2, R31 R4 and R5 are as defined with respect to formula IV and one of X1 and X2 represents amino, and the other represents an N acylating derivative of a carbamic acid group, NH.CO2H. 9. A process for the preparation of a compound as claimed in claim 1 which comprises reacting a compound of formula XIII EMI71.3 where R is as defined with respect to formula II andRY is hydrogen or a group which permits acylation to take place with a reactive N acylating derivative of a compound of formula XIV EMI72.1 wherein R1,R2,R3,R4 and R5 are as defined with respect to formula 11 10. A process for the preparation of a compound as claimed in claim 2 which comprises reacting a compound of formula XIIIa EMI72.2 where R, Rx and Y are as defined with respect to formula IV and RY is hydrogen or a group which permits acylation to take place with a reactive N acylating derivative of a compound of formula XIV EMI73.1 wherein R1, R2, R3, R4 and R5 are as defined with respect to formula IV 11. A process as claimed in any one of claims 5,6,9 or 10 in which the N acylating derivative is an acid halide, a symmetrical or mixed anhydride, an acid azide, an activated ester or the reactive intermediate formed by reaction in situ with a condensing agent. 12. A compound as claimed, in claim 2 selected from the following or a salt thereof 6ss D 2 2 N ethyl N 4 nitrobenzyloxalyl amino ethylaminozearbonylamino 2 phenylacetamido 6a methylthio penicillanic acid or the benzyl ester thereof 6ss D 2 2 N ethyl N 4 nitrobenzyloxalyl amino ethylamino carbonylamino 2 3,4 diacetoxyphenyl acetamido 6a formamidopenicillanic acid or the benzyl ester thereof 6ss D 2 2 N ethyl N methyloxalyl amino ethylamino carbonylamino 2 phenylacetamido 6 alpha methylthio penicillanic acid or the benzyl ester thereof 6ss D 2 2 N ethyl N 4 nitrobenzyloxalyl amino ethylamino carbonylamino 2 3,4 diacetoxyphenyl acetamido 6 alpha methylthio penicillanic acid or the benzyl ester thereof. 6ss D 2 2 N ethyl N methyloxalyl amino ethylamino carbonylamino 2 3,4 diacetoxyphenyl acetamido 6 alpha methylthio penicillanic acid or the benzyl ester thereof. 6ss D 2 2 N ethyl N methyloxalyl amino ethylamino carbonylamino 2 3,4 diacetoxyphenyl acetamido 6 alpha formamidopenicillanic acid or the benzyl ester thereof. 7ss D 2 2 N ethyl N 4 nitrobenzyloxalyl amino ethylamino carbonylamino 2 phenylacetamido 7 alpha formamidocephalosporanic acid or the t butyl ester thereof. 13. A process for the preparation of a 13 lactam compound having the partial structure I EMI75.1 wherein R represents C16 alkyithio, arylthio, methoxy, hydroxymethyl, amino or formamido R1 represents hydrocarbon or heterocyclyl RÃª and R are the same or different and each represents hydrogen, optionally substituted C16 alkyl, halogen, aryl,amino, hydroxy or C1 6 alkoxy or R2 and R3 form the residue of a 5 or 6 membered carbocyclic or heterocyclic ring andR4 represents hydrogen, or hydrocarbon which process comprises cyclising a compound of formula II EMI76.1 wherein R, R1, R2, R3 and R4 are as defined above and R5 represents hydrogen or a group which allows the CO2R5 group to effect N acylation. 14. A process for the preparation of a compound of formula III or a salt thereofEMI76.2 wherein R represents C16 alkylthio, arylthio, methoxy, hydroxymethyl, amino or formamido R1 represents hydrocarbon or heterocyclyl R2 and R3 are the same or different and each represents hydrogen, optionally substituted C16 alkyl, halogen, aryl, amino, hydroxy or C1 6 alkoxy or R2 and R3 form the residue of a 5 or 6 membered carbocyclic or heterocyclic ring andR4 represents hydrogen, or hydrocarbon Rx is hydrogen or a carboxyl blocking group and Y is EMI77.1 wherein n is zero, 1 or 2 and Z represents hydrogen, halogen, or an organic group such as C14 alkoxy, CH2Q or CH CH O wherein Q represents hydrogen, halogen, hydroxy, mercapto, cyano, carboxy, carboxylic ester, carbamoyloxy, C14 alkyloxy, acyloxy, aryl, a heterocyclyl group bonded via carbon, a heterocyclylthio group or a nitrogen containing heterocyclic group bonded via nitrogen. which process comprises cyclising a compound of formula IV EMI78.1 wherein R, R1, R2,R3,R4,RX and Y are as defined above and R5 represents hydrogen or a group which allows the Co2R5 group to effect acylation, and thereafter carrying out one or more of the following steps i converting a group Rx into a different group Rx ii converting a group Z into a different group Z. 15. A process as claimed in claim 14 in which Y is S C CH3 2 or S CH2 CZ such that the compound of formula III is a derivative of penicillin or cephalosporin. 16. A process as claimed in claim 13 or claim 14 in which the cyclisation is carried out in a solvent in the presence of a base. 17. A process as claimed in claim 16 in which the solvent is water, C16 alkanol, an ether, ester, chlorinated hydrocarbon, aromatic hydrocarbon or amide. 18. A process as claimed in claim 17 in which the solvent is water, methanol, ethanol, tehahydrofuran, dioxan, methyl acetate, ethyl acetate, dichloromethane chloroform, benzene, toluene or dimethyl formamide. 19. A process as claimed in claim 18 in which the base is an alkali metal hydroxide, carbonate, hydride or alkoxide, an amine, or a strong non nucleophilic base. 20. A process as claimed in claim 19 in which the base is a tertiary amine. 21. A process as claimed in claim 20 in which the base is a trialkylamine, dialkylbenzylamine, 4 dimethylamino pyridine or methyl morpholine. 22. A process as claimed in claim 19 in which the non nucleophilic base is l,5 diazabicycloE5.4.0 undec 7 ene. 23. A process as claimed in any one of claims 13 to 22 in which R is formamido. 24. A process as claimed in any one of claims 13 to 23 in which R1 is 3,4 dihydroxyphenyl, 3,4 diacetoxyphenyl or 3,4 dibenzyloxycarbonyloxyphenyl. 25. A compound of the formula IX EMI79.1 wherein R2, R3, R4 and R5 are as defined with respect to formula IV and x2 represents amino or an N acylating derivative of a carbamic acid group, NH.CO2H. 26. A process for the preparation of a compound of formula XIV EMI80.1 wherein R1, R2, R3, R4 and R5 are as defined in claim 8 which comprises reacting a compound of formula XV EMI80.2 with a compound of formula IX EMI80.3 wherein R1, R2, R3, R4, R5, RX, X1 and X2 are as defined in claim 8 and if necessary removing any carboxyl blocking group. 27. A process for the preparation of a compound of formula XIV EMI81.1 wherein R1, R2, R3, R4 and R5 are as defined in claim 8 which comprises reacting a compound of formula XVI EMI81.2 wherein R1, R2, R3, R4 and Rx are as defined in claim 8 with a reactive N acylating derivative of an acid formula VI R502C.C02H vI wherein R5 is as defined in claim 8 and thereafter if necessary removing any blocking group RX. 28. A compound of the formula XIV EMI82.1 wherein R1 is a 3,4 dihydroxyphenyl or protected 3,4 dihydroxyphenyl group and R2, R3, R4 and R5 are as defined in claim 8. 29. A compound as claimed in claim 28 in which R2 andR3 represent hydrogen and R4 represents C16 alkyl. 30. A compound as claimed in claim 28 selected from the following or a salt thereof D 2 2 N Ethyl N 4 nitrobenzyloxalyl amino ethylaminozearbonylamino 2 3,4 dihydroxyphenyl acetic acidD 2 2 N Ethyl N 4 nitrobenzyloxalyl amino ethylamino carbonylamino 2 3,4 diacetoxyphenyl acetic acid

## Description
CHEMICAL PROCESSThis invention relates to a chemical process for preparing a class of p lactam compounds. The p lactam compounds produced by this process have antibacterial activity and are therefore useful in the treatment of bacterial infections in animals, especially mammals including man caused by a wide range of organisms, particularly Gram negative organisms.The present invention provides a process for the preparation of a lactam compound having the partial structure I EMI1.1 wherein R represents C16 alkyltbio, arylthio, methoxy, hydroxymethyl, amino or formamido R1 represents hydrocarbon or heterocyclyl R2 and R3 are the same or different and each represents hydrogen, optionally substituted C16 alkyl, halogen,aryl amino, hydroxy or C16 alkoxy or R2 and R3 form the residue of a 5 or 6 membered carbocyclic or heterocyclic ring andR4 represents hydrogen, or hydrocarbon which process comprises cyclising a compound of formula 11 EMI2.1 wherein R, R1, R21 R3 and R4 are as defined with respect to formula I , and R5 represents hydrogen or a group which allows the C02R5 group to effectN acylation.In particular, the compounds of formula I produced by the process of this invention may have the formula III EMI3.1 wherein R, R1, R2, R3 and R4 are as defined with respect to formula I Rx is hydrogen or a carboxyl blocking group and Y is EMI3.2 wherein n is zero, 1 or 2 and Z represents hydrogen, halogen, or an organic group such as C1 4 alkoxy, CH2Q or CH CH Q wherein Q represents hydrogen, halogen, hydroxy, mercapto, cyano, carboxy, carboxylic ester, carbamoyloxy, C14 alkyloxy, acyloxy, aryl, a heterocyclyl group bonded via carbon, a heterocyclylthio group or a nitrogen containing heterocyclic group bonded via nitrogen.Preferred values for Y in the compounds of formula III are S C CH3 2 and S CH2CZ , ie when the compound of formula III is a derivative of a penicillin or cephalosporin.Those compounds of the formula III wherein Rx is a readily removable carboxyl protecting group or a non pharmaceutically acceptable salt are primarily useful as intermediates in the preparation of compounds wherein Rx is hydrogen or a pharmaceutically acceptable salting ion, which compounds are useful as antibacterial agents. Also included within the readily removable carboxyl protecting groups Rx are pharmaceutically acceptable in vivo hydrolysable ester groups.Those compounds of the formula III wherein Y is SO CH CZ are primarily useful as intermediates in the preparation of compounds wherein Y is SO CH2 CZ .The compounds of formula II and iii wherein R is C16 alkylthio, arylthio or amino are useful intermediates for conversion into compounds wherein R is methoxy or formamido.Although the purity of the intermediate compounds of the present invention is less critical than for compounds used in pharmaceutical compositions it will readily be understood that the substantially pure form is preferred as for the 5 lactam antibiotic compounds.Preferably, whenever possible, the compounds of the present invention are obtained in crystalline form. The term hydrocarbon includes groups having up to 18 carbon atoms, suitably up to 10 carbon atoms, conveniently up to 6 carbon atoms. Suitable hydrocarbon groups include C1 6 alkyl, C26 alkenyl, C26 alkynyl, C37 cycloalkyl, C3 7 cycloalkyl C1 6 alkyl, aryl, and aryl C1 6 alkyl.The alkyl group may be straight or branched chain and may contain, fr example, up to 12 carbon atoms1 suitably from L to 6 carbon atoms. In particular the group may be sllbstituted methyl, ethyl, n , or iso propyl, or n , sec , iso or tert butyl.The term heterocyclyl includes single or fused rings compriaing up to four hetero atoms in the ring selected from oxygen, nitrogen and sulphur and optionally substituted with up to three halogen, C16 alkyl, C16 alkoxy, halo C1 6 alkyl, hydroxy, amino, carboxy,C1 6 alkoxycarbonyl, C1 6 alkoxycarbonyl C1 6 alkyl, aryl or oxo groups.Suitably the heterocyclic ring comprises from 4 to 7 ring atoms, preferably 5 to 6 atoms.When used herein the term aryl includes phenyl and naphthyl optionally substituted with up to five, preferably up to three, groups selected from halogen,C1 6 alkyl, phenyl, C1 6 alkoxy, halo C1 6 alkyl, hydroxy, amino, nitro, carboxy, C1 6 alkoxycarbonyl,C1 6 alkoxycarbonyl C1 6 alkyl, C1 6 alkylcarbonyloxy, C1 6 alkylcarbonyl or C1 6 alkoxycarbonyloxy groups.Suitable optional substituents for the hydrocarbon, heterocyclic groups and organic radicals include C1 6 alkyl, heterocyclyl, amino, C1 6 alkanoyl amino, mono, and di C16 alkylamino, hydroxy, C16 alkoxy, mercapto1 C1 6 alkylthio, heterocyclyl thio, arylthio, sulphamoyl, carbamoyl, amidino, guanidino, nitro, chloro, bromo, fluoro, carboxy and salts and esters thereof, C16 alkanoyloxy, aryl carbonyl and heterocyclylcarbonyl.Suitable carboxyl blocking derivatives for the group C02RX in formula III include salts and ester derivatives of the carboxylic acid. The derivative is preferably one which may readily be cleaved at a later stage of the reaction. Suitable salts include metal salts, such as those with sodium1 potassium and lithium, and tertiary amine salts such as those with trilower alkylamines, N ethylpiperidine, 2,6 lutidine, pyridine, N methylpyrrolidine, dimethylpiperazine. A preferred salt is with triethylamine. Suitable ester forming carboxyl protecting groups are those which may be removed under conventional conditions. Such groups for Rx include benzyl, p methoxybenzyl, 2,4,6 trimethylbenzyl, 3,5 di t butyl 4 hydroxy benzyl, benzoylmethyl, p nitrobenzyl, 4 pyridylmethyl, 2,2,2 trichloroethyl, 2,2,2 tribromoethyl, allyl, acetonyl, t butyl, t amyl, diphenylmethyl, triphenylmethyl, adamantyl, 2 benzyl oxyphenyl, 4 methylthiophenyl, tetrahydrofur 2 yl, tetrahydropyran 2 yl, pentachlorophenyl, p toluene sulphonylethyl, methoxymethyl, a silyl, stannyl or phosphorus containing group, an oxime radical of formula N CHR whereinR is aryl or heterocyclic, or an in vivo hydrolysable ester radical. The carboxyl group may be regenerated from any of the above esters by usual methods appropriate to the particular Rx group, for example, acid and base catalysed hydrolysis, or by enzymically catalysed hydrolysis, or by hydrogenation.Suitable pharmaceutically acceptable salts of the compounds of formula III include metal salts, such as for example aluminium, alkali metal salts such as sodium or potassium, alkaline earth metal salts such as calcium or magnesium and ammonium or substituted ammonium salts, for example those with lower alkylamines such as triethylamine, hydroxy lower alkylamines such as 2 hydroxyethylamine, bis 2 hydroxyethyl amine or tri 2 hydroxyethyl amine, cycloalkylamines such as bicyclohexylamine, or with procaine, dibenzylpiperidine, N benzyl 13 phenethylamine, dehydroabietylamine, N,N bisdehydroabietylamine, glucamine, N methylglucamine or bases of the pyridine type such as pyridine, collidine or quinoline.Suitable values for Q in the compounds of the formula III include the acetoxy, heterocyclylthio group, and nitrogen containing heterocyclic group bonded via nitrogen.More suitably Q represents the acetoxy or heterocyclylthio group.The heterocyclylthio group may suitably be represented by the formula S Het wherein Het is a five or six membered heterocyclic ring containing from 1 to 4 atoms selected from N, 0, and S unsubstituted or substituted with one or two groups selected from C16 alkyl, C16 alkoxy, hydroxyalkyl, C16 alkenyl, alkoxyalkyl, sulphonylalkyl, carbamoylalkyl, trifluoromethyl, hydroxy, halogen, oxo, aminoalkyl, or substituted aminoalkyl and carboxy alkyl or two substituents may be linked to form the residue of a heterocyclic or carbocyclic ring.Examples of the group Het include unsubstituted and substituted imidazolyl, triazolyl, tetrazolyl, thiazolyl, thiadiazolyl, thiatriazolyl, oxazolyl, triazinyl and oxadiazolyl.Suitable groups Het include unsubstituted and substituted 1, 2, 3 triazolyl 1, 2, 4 triazolyl tetrazolyl oxazolyl thiazolyl 1, 3, 4 oxadiazolyl 1, 3, 4 thiadiazolyl, or 1, 2, 4 thiadiazolyl.Preferably the heterocyclylthio group is l methyl lH tetrazol 5 ylthio, 2 methyl 1,3,4 thiadiazol 5 ylthio, 1 carboxymethyl lH tetrazol 5 ylthio or 6 hydroxy 2 methyl 5 oxo 2H 1,2,4 triazin 3 ylthio.The nitrogen containing heterocyclic group bonded via nitrogen is suitably a pyridinium group unsubstituted or substituted with one or two groups selected from C16 alkyl, C16 alkoxy, hydroxyalkyl, C16 alkenyl, alkoxyalkyl, carboxyalkyl, sulphonylalkyl, carbamoylmethyl, carbamoyl, trifluoromethyl, hydroxy, halogen, oxo, aminoalkyl or two substitutents may be linked to form the residue of a carbocyclic ring.The group R as used herein suitably represents methylthio, phenylthio, tolylthio, methoxy, amino hydroxymethyl, or formamido. Preferably R represents methylthio or formamido.Suitably the group R1 represents phenyl, phenyl substituted with up to three groups selected from hydroxy, C16 alkylcarbonyloxy, C16 alkoxycarbonyloxy and halogen cyclohexenyl, cyclohexadienyl or a 5 or 6 membered heterocyclic ring containing up to three hetero atoms selected from oxygen, sulphur or nitrogen, optionally substituted with hydroxy, amino, halogen, substituted amino or C16 alkoxy.Preferably the group R1 is phenyl, 4 hydroxyphenyl, 3,4 di Cl,galkylcarbonyloxy phenyl, 3,4dibenzyloxycarbonyloxyphenyl, 3,4 dihydroxy phenyl, 2 thienyl, 3 thienyl or 2 amino 4 thiazolyl.Particularly preferred groups R1 are 3,4 dihydroxy phenyll 3,4 diacetoxyphenyl and 3,4 dibenzyloxy carbonyloxyphenyl.Suitable Ci 6 alkyl groups for the groups R2, R3 and R4 in formulae I , II and III include methyl, ethyl, n and iso propyl, n, sec , iso and tert butyl.Preferably R4 is ethyl. Preferably R2 and R3 are hydrogen.The group R5 is suitably a hydrocarbon group, in particular C16 alkyl, aryl, and aryl C1 6 alkyl. In particular, R5 may represent methyl, ethyl, phenyl, benzyl and p nitrobenzyl.The cyclisation process of this invention is suitably carried out in a solvent, in the presence of a base.Suitable solvents include water, C16 alkanols, such as methanol and ethanol, ethers such as tetrahydrofuran and dioxan, esters such as methyl acetate and ethyl acetate, chlorinated hydrocarbons such as dichloromethane and chloroform, aromatic hydrocarbons such as benzene and toluene, and amides such as dimethylformamide.The base which is utilised in the present process may be, for example, an alkali metal hydroxide, carbonate, hydride or alkoxide, or a secondary or tertiary amine such as trialkylamine or dialkylbenzylamine or a heterocyclic amine such as pyridine or morpholine optionally substituted with an alkyl or alkylsubstituted amino group. Such amines include 4 dimethylamino pyridine and N methylmorpholine. Preferably the base is a strong non nucleophilic base such as diazabicycloundecene, diazabicyclononene and diazabicyclooctane. A preferred base is 1, 8 diazabicyclo 5.4.0 undec 7 ene. The reaction may be carried out at a temperature, dependent on the chosen solvent, from 200C to 500C, suitably from OOC to 350C, preferably from 150C to 200C.In the above process, any reactive substituents may be blocked by conventional blocking groups and removed at the end of the cyclisation reaction.When the compound resulting from the cyclisation process is a A2 cephem it can advantageously be converted to a 83 cephem sulphoxide, by oxidation with a conventional sulphoxide forming reagent such as a peracid or periodate and, if necessary, rearranging the double bond with a base such as a tertiary amine or alkali metal hydroxide. The d3 cephem sulphoxide may then be reduced to a t3 cephem, by conventional methods, for example those described in British PatentSpecification 1,280,693.The intermediates of formula II are novel compounds and form a further aspect of this invention. A particular subclass of novel intermediates has the formula IV EMI11.1 wherein R, R1, R2, R3, R4 and R5 are as defined with respect for formula II and Rx and Y are as defined with respect to formula III . Compounds of formula II may be prepared by a process which comprises reacting a compound of partial stucture V EMI12.1 wherein R, R1, R2, R3 and R4 are as defined with respect to formula I with a reactive N acylating derivative of an acid of formula VI R502C.C02H vI wherein R5 is as defined with respect to formula IT . Thus preferred compounds of formula IV may be prepared by a process which comprises reacting a compound of partial structure Va EMI13.1 wherein R, R1, R2, R3 and R4 are as defined with respect to formula I and Rx and Y are as defined with respect to formula III with a reactive N acylating derivative of an acid of formula VI R502C.Co2H vI wherein R5 is as defined with respect to formula II . Suitable N acylating derivatives include an acid halide, preferably the acid chloride or bromide.Acylation with an acid halide may be effected in the presence of an acid binding agent for example, tertiary amine such as triethylamine or dimethylaniline , an inorganic base such as calcium carbonate or sodium bicarbonate or an oxirane, which binds hydrogen halide liberated in the acylation reaction. The oxirane is preferably a C16 1,2 alkylene oxide such as ethylene oxide or propylene oxide.The acylation reaction using an acid halide may be carried out at a temperature in the range 500C to 500C, preferably 2O0C to 200C, in aqueous or non aqueous media such as water, tetrahydrofuran, dimethylacetamide, dimethylformamide, acetonitrile, dichloromethane, chloroform, 1,2 dichloroethane, an aliphatic ester such as ethyl acetate or butyl acetate, an aliphatic ketone such as acetone or 4 methylpentan 2 one, or mixtures thereof.Alternatively, the N acylating derivative of the acid VI may be a symmetrical or mixed anhydride. Suitable mixed anhydrides are alkoxyformic anhydrides, or anhydrides with, for example, carbonic acid monoesters, trimethyl acetic acid, thioacetic acid, diphenylacetic acid, benzoic acid, phosphorus acids such as phosphoric or phosphorous acids or aliphatic or aromatic sulphonic acids such as p toluenesulphonic acid . When a symmetrical anhydride is employed, the reaction may be carried out in the presence of 2,6 lutidine as catalyst.Alternative N acylating derivatives of acid VI are the acid azide, or activated esters such as esters with 2 mercaptopyridine, cyanomethanol, p nitrophenol, 2,4 dinitrophenol, thiophenol, halophenols, including pentachlorophenol, monomethoxyphenol, N hydroxy succinimide, or 8 hydroxyquinoline or amides such asN acylsaccharins, N acylthiazolidin 2 thione orN acylphthalimides or an alkylidene iminoester prepared by reaction of the acid VI with an oxime. Other reactive N acylating derivatives of the acid VI include the reactive intermediates formed y reaction in situ with a condensing agent such as a carbodiimide, for example, N,N diethyl , dipropyl or diisopropylcarbodiimide, N,N di cyclohexyl carbodiimide, or N ethyl N 3 dimethylamino propyl carbodiimide a suitable carbonyl compound, for example,N,N carbonyldiimidazole or N,N carbonylditriazole an isoxazolinium salt, for example,N ethyl 5 phenylisoxolinium 3 sulphonate or N 7 butyl 5 methylisoxazolinium perchlorate or anN alkoxycarbonyl 2 alkoxy 1,2 dihydroquinoline, such as N ethoxycarbonyl 2 ethoxy 1,2 dihydroquinoline.Other condensing agents include Lewis acids for example BBr3 C6H6 or a phosphoric acid condensing agent such as diethylphosphorylcyanide. The condensation reaction is preferably carried out in an organic reaction medium, for example, methylene chloride, dimethylformamide, acetonitrile, alcohol, benzene, dioxan or tetrahydrofuran.The compound of formula V or Va may be prepared by reacting a compound of partial structure VII EMI15.1 or a compound of formula VIIa EMI15.2 wherein R and R1 are as defined with respect to formula I and Y and Rx are as defined with respect to formula III with a compound of formula VIII EMI16.1 wherein R2, R3 and R4 are as defined with respect to formula I and R6 is a removable amino protecting group, one of X1 and X2 represents amino and the other represents an N acylating derivative of a carbamic acid group, NH.C02H and thereafter removing protecting group R6.Examples of N protecting groups in R6 include C1 6 alkanoyl, for example acetyl, propionyl n and isobutyryl and 2,2 dimethylpropanoyl, benzoyl or benzene optionally substituted in the phenyl ring by one or two substituents selected from C14 alkyl, C14 alkoxy, trifluoromethyl, halogen or nitro and C14 alkoxycarbonyl, for example tert butoxycarbonyl or 2,2,2 trichloroethoxycarbonyl, or benzyl optionally substituted as for benzoyl above. Particular examples of R6 protecting groups include those listed above for N protecting groups which are hydrogenolysable.Removal of the protecting group R6 may be effected by conventional methods. For example, when R6 is C16 alkanoyl or optionally substituted benzoyl as defined, removal is conveniently effected by conventional base hydrolysis. then R6 is C14 alkoxycarbonyl or optionally substituted benzyloxycarbonyl as defined, removal may be carried out by hydrogenolysis. Suitable reactions are conventional transition metal catalysed hydrogenation, using for example palladium , or platinum , charcoal, at atmospheric pressure or a slight excess thereover. An inert polar solvent such as ethanol and ambient temperatures are apt. Then the group X1 or X2 represents an N acylating derivative of a group NH.C02H, a preferred N acylating derivative is the isocyanate group N C O.Other suitable N acylating derivatives include the acid halide, preferably the acid chloride, NH.COC1, or activated esters, such as esters with 2 mercaptopyridine, cyanomethanol, trichloromethanol, p nitrophenol, 2,4 dinitrophenol, thiophenol, halophenols, including pentachlorophenol, monomethoxyphenol, N hydroxy succinimide, or 8 hydroxyquinoline or amides formed from amines such as saccharins, thiazolidin 2 thione, phthalimides, imidazole or triazole.A preferred activated ester is the p nitrophenyl ester, NH.C02C6H4N02, and a preferred thiol ester is the thiophenol ester, NHCOSC6H5. The free carbamic acid, i.e. a compound where X1 or X2 is NH.C02H, is not generally sufficiently stable to isolate.The compounds of formulae VII , VIIa and VIII wherein X1 or X2 is an N acylating derivative of a group NH. CO2H may be prepared from the corresponding compound where X1 or X2 represents amino, by conventional methods. For example the preferredN acylating derivative, the isocyanate, where X1 or X2 is N C O, may be prepared by reacting the compound wherein X1 or X2 is amino, with phosgene.The acid chloride, where X1 or X2 is NH.COC1, may be generated from the amino compound by reaction with phosgene, and employed in situ. The activated esters may be prepared from the corresponding chloroformate derivative of the alcohol, phenol or thiophenol. The activated amides may be prepared from the corresponding carbonyl compound for example N,N1 carbonyldiimidazole or N,N carbonylditriazole.In the reaction between compound VII or VIIa and compound VIII , preferably X1 represents amino and X2 represents an N acylating derivative, in particular the isocyanate group of formula N C O. Alternatively, the novel intermediates of formula II or IV may be prepared by reacting a compound of formula VII or VIIa with a compound of formula IX EMI18.1 wherein R2, R3, R4, R5, and X2 are as defined above. The compounds of formula IX are also novel compounds, both when X2 represents amino and when X2 represents anN acylating derivative of the group NH.C02H, and form a further aspect of this invention. Those compounds wherein X2 represents an N acylating derivative may be prepared from the compound wherein X2 represents amino by the methods described above.The compounds of formulae VIII and IX which have the most utility as intermediates are compounds VIII where X2 represents an N acylating derivative of the group NH.C02H, and compounds IX where X2 represents either amino or an N acylating derivative of a group NH. CO2H. The compounds of formula IX where X2 represents amino may be prepared by reacting a compound of formula X EMI19.1 wherein R2, R3 and R4 are as defined above, and R7 is an amino protecting group with a reactive N acylating derivative of an acid of formula VI as described above and subsequently removing the amino protecting group. Suitable amino protecting groups R7 are those well known in the art which may be removed under conventional conditions without disruption of the remainder of the molecule.Examples of suitable groups R7 which may subsequently be converted to NH2 by mild acid hydrolysis include groups of formula XI or tautomeric modifications thereof EMI20.1 wherein R8 is C16 alkyl, R9 is hydrogen or C16 alkyl,R10 is C1 6 alkyl, aryl or C16 alkoxy or R9 together with either R8 or R10 completes a carbocyclic ring.Preferably R8 is methyl, R9 is hydrogen and R10 is methoxy.Compounds of formula VIII , where X2 is amino, may be prepared by protecting compound X with an amino protecting group R6, and subsequently removing the protecting group R7.Compounds of formula X , may be prepared by amino protection of the compound of formula XII EMI20.2 Compounds of formula II or of formula IV may also be prepared by reacting a compound of formula XIII EMI21.1 or a compound of formula XIIIa EMI21.2 where R is as defined above, Y and Rx are as defined with respect to formula III and Ry represents hydrogen or a group which permits acylation to take place with a reactive N acylating derivative of a compound of formula XIV EMI21.3 wherein R1, R2, R3, R4 and R5 are as defined above. Suitable reactive N acylating derivatives of the acid XIV are as described above with respect to the acid or . Suitable groups which permit acylation to take place and which are optionally present on the amino group of the starting material of the formula XIII or XIIIa include N silyl, N stannyl and N phosphorus groups, for example trialkylsilyl groups such as trimethylsilyl, trialkyltin groups such as tri n butyltin, groups of formula P.RaRb where inRa is an alkyl, haloalkyl, aryl, aralkyl, alkoxy, haloalkyl, aryl, aralkyl, alkoxy, haloalkoxy, aryloxy, aralkyloxy or dialkylamino group,Rb is the same as Ra or is halogen orRa and Rb together form a ring suitable such phosphorus groups being P OC2H5 2, P C2H5 2, EMI22.1 Compounds of formula XIV are generally described inJapanese patent application no. 112605 77 Kokai 46799 79 . However, in a further aspect of the present invention, there is provided an improved process for the preparation of a compound of formula XIV , which process comprises reaction of a compound of formula XV EMI22.2 wherein R1, Rx and X1 are as hereinbefore defined with a compound of formula IX as hereinbefore defined and thereafter if necessary removing any blocking group RX. The comments above relating to RX, X1 and X2 also relate to this process.A further novel process for the preparation of compounds of formula XIV comprises reacting a compound of formula XVI EMI23.1 wherein R1, R2, R3, R4 and Rx are as hereinbefore defined with a reactive N acylating derivative of an acid of formula VI R502C.C02H VI as hereinbefore defined and thereafter if necessary removing any blocking group RX. Furthermore the present invention also comprises a class of compounds within the general definition of formula XIV , which are not disclosed in Japanese application 112605 77, namely compounds of formula XIV wherein R1 represents a dihydroxyphenyl or protected dihydroxyphenyl group.Within compounds XIV , preferably R1 represents 3, 4 dihydroxyphenyl, 3,4 diacetoxyphenyl, 3,4 diethoxycarbonyloxyphenyl or 3,4 dibenzyloxycarbonyloxyphenyl. PreferablyR represents 3,4 dihydroxyphenyl. Preferably R2 and R3 represent hydrogen. Preferably R4 represents C16 alkyl, in particular ethyl. The following Examples illustrate the present invention. Preparation 1 4 Nitrobenzyl N 2 isocyanatoethyi N ethylamino oxaiate i Methyl 3 2 ethylamino ethylamino but 2 enoate A solution of N ethylethylenediamine 5.3 ml, 4.4 g, 50 mmol and methyl acetoacetate 5.4 ml, 5.8 g, 50 mmol in dichloromethane 125 ml was ref fluxed under argon for 4 h, then filtered through a short plug of silica, and evaporated to dryness giving the product as a colourless oil 9.25 g1 99.5 , max. CHC13 3300 br, 2950, 1645, 1605, 1550, 1500, 1440, and 1380 cm 1 6 90 MHz, CDC13 1.10 3H, t, J 7.5 Hz, NCH2CH3 , 1.40 1H, s, NHCH2CH3 , 1.90 3H, s, CH3C C , 2.62 2H, t, J 7.5 Hz, CH2NCH2CH3 , 2.77 2H, t, J 7.5 Hz, CH2NC C , 3.30 2H, q, J 7.5 Hz, NCH2CH3 , 3.57 3H, s, C02CH3 , 4.43 1H, s, C CH , and 8.60 1H, br s, NHC C Found M , 186.1367 C9H18N202 requires M, 186.1368 . ii Methyl 3 2 N ethyl N 4 nitrobenzyloxalyl amino ethylamino but 2 enoate 4 Nitrobenzyloxalyl chloride 2.44 g, 0.01 mol in dichloromethane 15 ml was added dropwise with stirring to a solution of methyl 3 2 ethylamino ethylamino but 2 enoate 1.86 g, 0.01 mol and N,N diisopropylethylamine 1.29 g, 0.01 mol in dichloromethane 20 ml at OOC. The solution was allowed to warm slowly to room temperature over 3 h and it was then evaporated to dryness, and the residue quickly chromatographed on silica gel 60 eluting with hexane ethyl acetate 2 3 to afford the essentially pure product 2.60 g, 66 as a yellow oil 9max. CH2C12 1745, 1660, 1610, 1525, 1350 cm l n.m.r. showed two isomers, ratio 2 1, 6 CDC13 1.15 and 1.17 3H, 2t, J 7Hz, 2 CH2CH3 , 1.83 and 1.91 3H, 2s, CH3C C , 3.10 3.70 9H, m, 3 NCH2 and CH302C , 4.46 1H, s, C CH , 5.35 2H, s, C2Ar , 7.54 and 8.18 4H, AA1BB1, J 9Hz, aromatics and 8.55 1H, br s, NH Found M , 393.1545.C18H23N307 requires M, 393.1536 . iii 2 N Ethyl N 4 nitrobeznyloxalyl amino ethyl ammonium chloride A solution of methyl 3 2 N ethyl N 4 nitro bezyloxalyl amino ethylamino but 2 enoate 1.35 g, 3.44 mmol in acetone 13 ml was treated with 5 M hydrochloric acid 0.7 ml, 3.5 mmol and the solution was allowed to stand at room temperature for 0.5 h. It was then cooled in an ice bath and treated with ether ca. 5 ml , which caused immediate crystallisation.The solid was filtered off, washed with diethyl ether and then dried to afford the title compound 0.71 g, 63 m.p. 157 90C vmax. KBr 3300 2400 v. br., 1742, 1659, 1526, 1342, 1223, 1147 cm l 6 D20 1.30 3H, t, J 7Hz, NCH2CH3 , 3.30 3.70 4H, m, NCH2CH3 andNCH2 , 3.88 2H, t, J 6Hz, NCH2 , 5.59 2H, s, CH2Ar , 7.74 and 8.31 4H, AA1BB1, J 8Hz, aromatics Found C, 47.3 H, 5.5 N, 12.7 M H20, 277.1058.C13H18C1N305 requires C, 47.1 H, 5.5 N, 12.78 H2O, 277.1062 . iv 4 Nitrobenzyl N 2 isocyanatoethyl N ethylamino oxalate 2 N Ethyl N 4 nitrobenzyloxalyl amino ethylammonium chloride 166 mg, 0.5 mmol was suspended in dichloromethane 7 ml and the mixture was cooled to OOC. Triethylamine 152 mg, 1.5 mmol was then added and the resulting solution was treated with a 12.5 w w solution of phosgene in toluene 435 ul, 0.5 mmol . The reaction solution was stirred at 0 C for 5 min followed by 1 h at room temperature, and it was then evaporated to dryness. The residue was treated with tetrahydrofuran and the insoluble triethylamine hydrochloride was filtered off and dried 190 mg, 92 . The filtrate was evaporated to afford the title isocyanate max. CH2Cl2 2275, 1745, 1720, 1660, 1530, 1350 cm 1. preparation 2 2 ffi Ethyl X 2,2,2 trichloroethoxyzarbonyl aminojethyl ammonium chloride i Methyl 3 2 N ethyl N 2,2,2 trichloroethoxy carbonyBaminolethYlamino but 2 enoate Methyl 3 2 ethylamino ethylamino3but 2 enoate 1.86 g, 10 mmol was dissolved in anhydrous dichloromethane 35 ml containing triethylamine 1.5 ml, 10.5 mmol and cooled to 0 C with stirring. 2,2,2Trichloroethoxycarbonyl chloride 1.40 ml, 10.5 mmol was added in one portion precipitation of white solid was soon observed. The mixture was allowed to regain room temperature and stirred for a further 0.5 h, after which it was poured into ethyl acetate 100 ml and washed successively with 0.5 M hydrochloric acid 2 x 50 ml , saturated aqueous sodium hydrogen carbonate solution 50 ml , water and brine.The final extract was dried over anhydrous magnesium sulphate and evaporated to give the title compound as a pale yellow oil 3.14 g, 87 6 CDC13 1.2 3H, t, CH3CH2N , 1.9 3H, s, CH3C C , 3.0 3.7 9H, m, 3 x NCH2 OCH3 , 4.4 1H, s, CH C , 4.7 2H, s, C13CCH2O , 8.5 1H, br s,NH RF 0.80 in 10 methanol chloroform. ii 2 N Ethyl N 2,2, 2 trichloroethoxycarbonyl amino ethylammonium chloride Methyl 3 2 N ethyl N 2,2,2 trichloroethoxy carbonyl amino ethylamino but 2 enoate 2.66 g, 7.36 mmol in acetone 10 ml was treated with 2 M hydrochloric acid 3.7 ml . After 0.5 h, when no starting material was visible by t.l.c., the solution was diluted to 200 ml with ether, containing a little more acetone to prevent the separation of an aqueous phase. The precipitated solid was filtered, well washed with ether, dried and recrystallised from methanol ether to afford the amine hydrochloride 1.58 g, 63 , m.p. 157 158 C max. KBr 1699, 1591, 1491, 1473, 1452, 1431 cm 1 6 CD3 2SO 1.11 3H, t, CH3CH2N , 2.8 3.6 6H, m, 3NCH2 , 4.79 2H, s, C13CCH2O , 8.27 3H, br s, D2O exchanged, NH3 Found C, 28.0 H, 4.7 C1, 47.2 N, 9.3 C7H14Cl4N202 requires C, 28.0 H, 4.7 C1, 47.3 N, 9.3 . Example 1Benzyl 6 B D 2 2 N ethyl N 4 nitrobenzyloxalyl aminoi ethylaminolcarbonYlamino 2 phenylacetamido 6a methYl thio penicillanate method i 2 N Ethyl N 4 nitrobenzyloxalyl amino ethylammonium chloride 166 mg, 0.5 mmol was suspended in dichloromethane 7 ml , cooled to 0 C and treated with triethylamine 253 mg, 2.5 mmol . The resulting clear solution was treated in one portion with a 12.5 w w solution of phosgene in toluene 435 ul, 0.5 mmol , and it was then allowed to warm to room temperature over 1 h.The reaction solution was then cooled to 0 C and a solution of benzyl 6ss D 2 amino 2 phenylacetamido 6a methylthio penicillanate 243 mg, 0.5 mmol in dichloromethane 5 ml was added dropwise over approximately 1 min. The solution was stirred at 0 C for 5 min followed by 2.5 h at room temperature, before being evaporated to small volume, redissolved in ethyl acetate 40 ml and washed with 0.5 M hydrochloric acid and brine. The organic solution was dried over MgSO4, filtered and evaporated to leave the crude product which was chromatographed on silica gel 60 20 g eluting with hexane ethyl acetate 1 2 grading to 2 5 to afford the title compound 142 mg, 35 vmax. CH2C12 3380, 1785, 1745, 1655, 1525, 1350 cm l n.m.r.showed the presence of two isomers, 6 CDC13 0.92 and 0.96 3H, 2s, 2 CH3 , 1.00 1.23 6H, m, 2 CH3 andCH2CH3 , 2.28 3H, s, SCH3 , 3.13 3.63 6H, m, 3 NCH2 , 4.32 1H, s, 3 H , 5.11 and 5.17 2H, ABq, J 12Hz,CH2Ph , 5.19 and 5.28 1H, ABq, J 14Hz, CH2PNB isomer , 5.34 1H, s, CH2PNB isomer , 5.46 and 5.47 1H, 2s, 5 H isomers , 5.78 1H, m, CH2NHCO 5.88 and 5.98 1H, 2d,J 8Hz, CHNHCO isomers , 6.88 and 7.03 1H, 2d, J 8Hz,CHNHCO , 7.10 7.40 8H, m, aromatics , 7.40 7.60 4H, m, aromatics , 8.13 and 8.22 2H, AA BB , J 8Hz,PNB aromatics isomers , 8.29 and 8.50 1H, 2s, 6S NHCO Found MH , 807. C38H42N6O10S2 requires M, 806 . Example 2Benzyl 68 D 2 2 N ethyl N 4 nitrobenzyloxalyl amino ethylamino carbonylamino 2 phenylacetamido 6 alpha methyl thio penicillanate method ii 4 Nitrobenzyl N 2 isocyanatoethyl N ethylamino oxalate 0.25 mmol in dichloromethane 3 ml at 0 C was treated with a solution of benzyl 6ss D 2 amino 2 phenyl acetamido 6a methylthio penicillanate 122 mg, 0.25 mmol in dichloromethane 3 ml , and the reaction solution was stirred at 0 C for 0.5 h followed by 5 h at room temperature. The solution was then evaporated to dryness and the crude product was chromatographed on silica gel 60 eluting with hexane ethyl acetate 1 3 grading to 1 4 to afford the title compound 65 mg, 32 . Example 3Benzyl 6B D 2 4 ethyl 2,3 dioxopiperazin l yl carbonylamino 2 phenylacetamido 6 alpha methylthio penicillanateA 0.01 M solution of 1,8 diazabicyclo 5.4.0 undec 7 ene in dichloromethane 7.4 ml, 0.074 mmol was added to a solution of benzyl 6ss D 2 2 N ethyl N 4 nitrobenzyl oxalyl amino ethylamino carbonylamino 2 phenylacetamido 6a methylthio penicillanate 60 mg, 0.074 mmol in dichloromethane 6 ml , and the reaction solution was stirred at room temperature for 15 min. It was then washed with 0.25 M hydrochloric acid 2 x 10 ml and brine, before being evaporated to dryness.The residue was chromatographed on silica gel 60 eluting with ethyl acetate to afford the title compound 29 mg, 60 max. CH2C12 3390, 3300, 1780, 1742, 1718, 1690 cm 1 6 CDC13 0.96 3H, s, 2 CH3 , 1.21 6H, m, 2 CH3 andCH2CH3 2.28 3H, s, SCH3 , 3.40 3.70 4H, m, CH2CH3 and piperazine CH2 , 3.99 1H, m, piperazine CH , 4.18 1H, m, piperazine CH , 4.32 1H, s, 3 H , 5.12 and 5.19 2H, ABq, J 12Hz, C2Ph , 5.53 1H, s, 5 H , 5.60 1H, d, J 7Hz, NHCH , 7.07 1H, s, 6ss NHCO , 7.25 7.55 10H, m, aromatics , and 10.04 1H, d, J 7Hz, NHCH Found MH , 654. C31H35N5O7S2 requires M, 653 . Example 4Benzyl 6 B D 2 2 N ethyl N 4 nitrobenzyloxalyl amino ethylamino carbonylamino 2 3,4 diacetoxyphenyl acetamido 6 alpha formamidopenicillanate Benzyl 6ss D 2 2,2,2 trichloroethoxycarbonylamino 2 3,4 diacetoxyphenyl acetamido 6a formamidopenicillanate 630 mg, 0.814 mmol in tetrahydrofuran 15 ml was treated with 1 M potassium dihydrogen phosphate 3 ml and freshly acid washed zinc 1.0 g . The reaction mixture was stirred at pH 4 for 1 h before addition of more zinc 1.0 g . Reaction was continued at room temperature until complete by t.l.c. total of 2.5 h .The reaction mixture was filtered and the filtrate evaporated to small volume and diluted with ethyl acetate. The mixture was washed with brine, dried over MgS04 and then evaporated to leave benzyl 6ss D 2 amino 2 3,4 diacetoxyphenyl acetamido 6a formamidopenicillanate. This, in dichloromethane 10 ml , was then added dropwise to a solution of 4 nitrobenzyl 2 isocyanatoethyl N ethylamino oxalate 0.814 mmol in dichloromethane 10 ml at OOC. The reaction solution was stirred at 0 C for 0.5 h followed by 2 h at room temperature, and then it was evaporated to dryness. Chromatography of the residue on silica gel 60 eluting with 2 grading to 5 ethanol chloroform afforded the title compound 88 mg, 12 vmaXv CH2C12 3305, 1780, 1745, 1690, 1660, 1525, 1350, 1210r 1185 cm l n.m.r.showed two major isomers, 6 CD3 2CO 1.03 3H, s, 2 CH3 , 1.10 and 1.11 3H, 2t, J 7Hz, 2 CH3CH2 , 1.22 3H, s, 2 CH3 , 2.24 6H, s, 2 CH3C02 , 3.20 3.57 6H, m, 3 NCH2 , 4.41 and 4.42 1H, 3s, 3 H , 5.19 2H, s, CH2Ph , 5.41 1H, s, 5 H , 5.49 and 5.58 2H, 2s, CH2PNB isomers , 5.73 1H, d, J 7Hz, ArCHNH , 6.10 1H, m, CH2NHCO , 6.65 1H, m, ArCHNH , 7.15 1H, d, J 8Hz, aromatics , 7.30 7.50 7H, m, aromatics , 7.73 2H, m, PNB aromatics , 8.16 1H, s, NHCHO , 8.20 8.35 3H, m, PNB aromatics , 8.89 and 9.12 1H, s and d,NHCHO . Found MH , 920. C42H45N7015S requires M, 919 . Example 5Benzyl 6ss D 2 4 ethyl 2,3 dioxopiperazin 1 yl carbonylamino 2 3,4 diacetoxophenyl acetamido 6a formamidopenicillanateA solution of benzyl 6ss D 2 2 N ethyl N 4 nitro benzyloxalyl amino ethylamino carbonylamino 2 3,4 diacetoxyphenyl acetamido 6 alpha formamidopenicillanate 57 mg, 0.062 mmol in dichloromethane 10 ml was treated with a solution of 1,8 diazabicyclo 5.4.0 undec 7 ene 0.062 mmol in dichloromethane 1.24 ml and the reaction solution was stirred at room temperature for 15 min.It was then washed with 0.5 M hydrochloric acid and brine, and then dried over MgS04. After evaporation to dryness, the crude product was chromatographed on silic gel 60 eluting with ethyl acetate grading to 3 ethanol ethyl acetate to afford the title compound 22 mg, 46 vmax. CH2C12 2275, 1780, 1745, 1710 sh, 1690, 1500, 1210, 1185 cm 1 n.m.r. showed two rotamers, CD3 2CO 0.97 3H, s, 2 CH3 , 1.17 3H, t, J 7Hz, CH2CH3 , 1.22 3H, s, 2 CH3 , 2.25 and 2.27 6H, 2s, 2 x CH3C02 , 3.51 2H, q, J 7Hz, CH2CH3 , 3.67 2H, m, piperazine CH2 , 4.01 2H, m, piperazine CH2 , 4.39 and 4.48 1H, 2s, 3 H rotamers , 5.19 2H, s, CH2Ph , 5.58 1H, s, 5 H , 5.74 1H, d, J 7Hz, ArCHNH , 7.12 7.57 8H, .m, aromatics , 8.18 1H, s, NHCHO 8.28 1H, s, NHCHO , 8.94 and 9.15 1H, 2s, 6ss NHCO rotamers , 10.09 1H, d, J 7Hz, ArCHNH . Found MH , 767. C35H38N6012S requires M, 766 . Example 6Benzyl 68 D 2 112 E ethyl N 2,2,2 trichloroethoxy carbonyl amino ethylaminoicarbonylamino 2 phenyl acetamidol 6a methylthio penicillanate 2 N Ethyl N 2,2,2 trichloroethoxycarbonyl amino ethylammonium chloride 0.3 g, 1 mmol was suspended in anhydrous dichloromethane 10 ml and treated with triethylamine 0.7 ml, 5 mmol under argon. The clear solution which soon resulted was cooled to 0 C and stirred, then a solution of phosgene in toluene 12.5 w w, 0.9 ml, 1 mmol was added. The mixture was allowed to regain room temperature, then stirred for a further 0.5 h.An aliquot of the mixture, on dilution with anhydrous tetrahydrofuran, filtration and evaporation to dryness showed max. CHC13 2275, 1710 and 1530 cm l the bulk of the isocyanate was not isolated but immediately reacted as follows. The mixture was again cooled to 0 C and a solution of benzyl 6B D 2 amino 2 phenylacetamido 6a methylthio penicillanate 0.49 g, 1 mmol in anhydrous dichloromethane 5 ml was added dropwise. On again warming to room temperature a clear solution resulted stirring was continued for 0.5 h, then the solution was poured into EtOAc 70 ml and washed with 0.5 M hydrochloric acid 2 x 30 ml , saturated aqueous sodium hydrogen carbonate 2 x 30 ml , water and brine.The final extract was dried over anhydrous magnesium sulphate, evaporated to dryness, and chromatographed on silica gel 60 50 g , eluting with 3 methanol in chloroform. Appropriate fractions were pooled and evaporated to afford the title compound 0.59 g, 76 vmax. KBr 1782, 1745, 1715, 1644, 1546 cm l 6 CD3 2CO 1.05 1.25 9H, m, CH3 2C andCH3CH2N , 2.32 3H, s, CH3S , 3.25 3.45 6H, m, 3CH2N , 4.40 lH, s, 3 H , 4.81 2H, ABq, C13CCH2O , 5.21 2H, ABq, PhCH2O , 5,43 1H, s, 5 H , 5.64 1H, d, s on D2O exchange, CHNH , 6.0 1H, v brs, D2O exchanged,NH , 6.43 1H, t, D20 exchanged, CH2NH , 7.2 10H, m, ArH , 8.71 1H, s, D2O exchanged, 6 NH Rf 0.50 in 5 methanol chloroform Found MH , 774.C32H38C13N507S2 requires M 773 . Example 7Benzyl 6B D 2 4 ethyl 2,3 dioxopiperazin l y carbonylamino 2 phenylacetamido 6a methylthio penicillanate i Benzyl 66 D 2 2 N ethyl N methyloxalyl amino ethylamino j carbonylamino 2 phenylacetamido 6a methylthio penicillanateBenzyl 66 D 2 2 N ethyl N 2,2,2 trichloroethoxy carbonyl amino ethylamino carbonylamino 2 phenyl acetamido 6a methylthio penicillanate 380 mg, 0.49 mmol was dissolved in tetrahydrofuran 15 ml and 1 M potassium dihydrogen phosphate 3 ml was added. The mixture was stirred vigorously freshly acid washed zinc 0.8 g was added and the pH maintained around 3.0 4.0 by the addition of hydrochloric acid, the course of the reduction being monitored by t.l.c.After 1.5 h a further portion of zinc 0.5 g was added a further 0.5 h later, no starting material was visible by t.l.c. The solids were filtered and washed with water and ethyl acetate the aqueous phase was saturated with sodium chloride, the organic phase was separated and the aqueous phase was extracted twice more with ethyl acetate tetrahydrofuran, 1 1. The total organic extract was dried over anhydrous magnesium sulphate and evaporated to dryness the residue was used at once without further purification Rf ca. 0.1 in 10 methanol chloroform . It was suspended in dry dichloromethane 5 ml and treated with triethylamine 0.14 ml, 1 mmol when a virtually clear solution resulted this was cooled to OOC, stirred and treated with methyl oxalyl chloride 0.045 ml, 0.5 mmol . The solution was allowed to regain room temperature, then stirred for a further 0.5 h.Workup for a neutral product as described in Example 6 gave crude product 148 mg , which was chromatographed on silica gel 60 16 g eluting with 3 methanol chloroform, to afford the title compound 78 mg, 23 Rf 0.65 in 10 methanolchloroform max. KBr 1782, 1742, 1653, 1586 w 1550, 1495 cm 1 6 CD3 2CO1 1.11, 1.22 6H, 2s, CH3 2C , 1.13 3H, t, CH3CH2N , 2.32 3H, s, CH3S , 3.2 3.5 6H, m, 3 CH2N , 3.76 3H, s, CH30 , 4.41 1H, s, 3 H , 5.21 2H, ABq, PhCH2O , 5.43 1H, s, 5 H , 5.64 1H, d, CHNH , 6.01 1H, t, D2O exchanged,NHCH2 , 6.50 1H, d, D2O exchanged, NHCH , 7.2 7.6 10H, m, ArH , 8.72 1H, s, D2O exchanged, 6 NH .The spectrum is complicated by presumably rotational isomerism, giving doubling of some signals with roughly equal intensities for clarity, only one set of resonances is quoted Found MH , 686. C32E39N508S2 requires M, 685 . ii Benzyl 6ss D 2 4 ethyl 2,3 dioxopiperazin 1 yl carbonylamino 2 phenylacetamido 6a methylthio penicillanateBenzyl 6ss D 2 2 N ethyl N methyloxalyl amino ethyl amino carbonylamino 2 phenylacetamido 6a methylthio penicillanate 60 mg, 0.088 mmol was treated at room temperature with a 0.01 M solution of 1,8 diazabicyclo 5.4.0 undec 7 ene in dichloromethane 1 ml . T.l.c.showed little starting material remaining after 0.5 h after this time the solution was diluted with ethyl acetate 20 ml and worked up for a neutral fraction as in Example 6. The crude product 54 mg was chromatographed on silica gel 60 pooling and evaporation of appropriate fractions gave the title compound 24 mg, 42 , with identical spectral characteristics to those given in Example 3. Example 8Benzyl 6ss D 2 4 ethyl 2,3 dioxopiperazin 1 yl carbonylamino 2 phenylacetamido 6 alpha methylthio penicillanateIn addition to the use of 1,8 diazabicyclo 5.4.0 undec7 ene in dichloromethane as in example 3, benzyl 6ss D 2 2 N 4 nitrobenzyloxalyl amino ethylamino carbonylamino 2 phenylacetamido 6 alpha methylthio penicillanate has been cyclised to the title compound under the following conditions a Potassium carbonate in dimethylformamide 0.25 h at room temperature.b Triethylamine in dichloromethane 2 days at room temperature.c Triethylamine and 4 dimethylamino pyridine in dichloromethane 2 days at room temperature.d 4 Dimethylamino pyridine in dichloromethane 10 days at room temperature.e Potassium carbonate in acetone 16 h at room temperature. Example 9Benzyl 6ss D 2 2 N ethyl N 4 nitrobenzyloxalyl aminolethYlaminolcarbonylaminol 2 3,4 diacetoxyphenyl acetamido 6 alpha methylthio penicillanate Benzyl 6B D 2 2,2,2 trichloroethoxycarbonylamino 2 3,4 diacatoxyphenyl acetamido 6 alpha methylthio penicillanate 0.777 g, 1 mmol in tetrahydrofuran 15 ml was treated with 1 M potassium dihydrogen phosphate and freshly acid washed zinc powder 1 g .The reaction mixture was stirred at pH 4 for 0.75 h before addition of more zinc 1 g . The reaction was continued at room temperature until complete by t.l.c. total of 1.5 h . The reaction mixture was filtered and the filtrate evaporated to small volume and diluted with ethyl acetate. The solution was washed with brine, dried over MgSO4 and then evaporated to leave benzyl 6 D 2 amino 2 3, diacetoxyphenyl acetamido 6a methylthio penicillanate. This, in dichloromethane 10 ml , was then added dropwise to a solution of 4 nitrobenzyl N 2 isocyanatoethyl N ethylamino oxalate 1 mmol in dichloromethane 7 ml at OOC. The reaction solution was stirred at 0 C for 0.5 h followed by 1.5 h at room temperature, and then evaporated to dryness. Chromatography of the residue on silica gel 60 eluting with chloroform grading to 3 ethanol in chloroform afforded the title compound 0.231 g, 25 max. CH2C12 3380, 1778, 1745, 1655, 1525, 1350, 1210 cm l n.m.r. showed signals due to two isomers, CDC13 1.01 3H, s, 2 CH3 , 1.10 and 1.12 3H, 2t, J 7Hz, 2 x CH2C3 , 1.21 3H, s, 2 CH3 , 2.15 and 2.17 3H, 2s, 2 x SCH3 , 2.23 and 2.26 6H, 2s, 2 x OCOCH3 , 3.16 3.60 6H, m, 3 x NCH2 , 4.33 1H, s, 3 H , 5.13 2H, s, CH2Ph , 5.29 and 5.35 2H, br.s and s, 2 x Ar CH2 , 5.46 and 5.47 lH, 2s, 2 x 5 H , 5.74 lH, m, CH2NHCO , 5.92 and 6.00 lH, 2d, J8Hz, 2 x CHNHCO , 6.72 1H, m, CHNHCO , 7.00 and 7.02 1H, 2d, J 8Hz, aromatic CH , 7.20 7.45 7H, m, aromatic , 7.52 and 8.17, and 7.57 and 8.22 4H, 2 x AA BB , nitrophenyl , and 8.63 and 8.78 1H, 2 br.s, 2 x 6ss NHCO . Example 10Benzyl 6ss D 2 4 ethyl 2,3 dioxopiperazin 1 yl carbonylamino 2 3,4 diacetoxyphenyl acetamido 6 alpha methylthio penicillanate A solution of benzyl 6ss D 2 2 N ethyl N 4 nitro benzylOxalyl amino ethylamino carbonylamino 2 3,4 diacetoxyphenyl acetamido 6a methylthio penicillanate 0.092 g, 0.1 mmol in dichloromethane 9 ml was treated with a 0.1 M solution of 1,8 diazabicyclo 5.4.0 undec 7 ene in dichloromethane 1 ml, 0.1 mmol and the reaction solution was stirred at room temperature for 0.25 h. It was then diluted with dichloromethane, washed with 0.5 M hydrochloric acid and brine, and then dried over magnesium sulphate.After evaporation to dryness, the crude product was chromatographed on silica gel 60 eluting with hexane ethyl acetate 1 4 grading to ethyl acetate to afford the title compound 0.022 g, 29 vmax. CH2C12 3280, 1780, 1745, 1715, 1695, 1500, 1210, 1185 cm 1 6 CDCl3 0.95 3H, s, 2 CH3 , 1.23 6H, m, 2 CH3 andCH2CH3 , 2.23 3H, s, SCH3 , 2.24 and 2.26 6H, 2s, 2 x OCOCH3 ,3.55 4H, m, piperazine CH2 and NC2CH3 , 3.90 4.09 1H, m, piperazine CH , 4.09 4.22 1H, m, piperazine CH , 4.32 1H, s, 3 H , 5.13 and 5.17 2H, ABq, J 12Hz, CH2Ph , 5.51 1H, s, 5 H , 5.78 1H, d, J 7Hz, NHCHCO , 7.11 1H, d, J 8Hz, aromatic H , 7.24 7.45 7H, m, aromatics, 7.71 1H, s, 6 NHCO , and 10.18 1H, d, J 7Hz, CHNHCO Found m z positive xenon F.A.B. MH 770.C35H39N5011S2 requires M 769 . Example 11D 2 2 N Ethyl N 4 nitrobenzyloxalyl amino ethylamino carbonylamino 2 phenylacetic acidD Phenylglycine 0.302 g, 2 mmol was suspended in hexamethyldisilazane 5 ml containing chlorotrimethylsilane 0.5 ml and heated at reflux under argon for 6 h. The resulting solution was evaporated to dryness, treated with toluene and re evaporated. The residue was then dissolved in dichloromethane 10 ml , and a solution of 4 nitrobenzyl N 2 isocyanatoethyl N ethylamino oxalate 2 mmol in dichloromethane 12 ml was added. The reaction solution was stirred at room temperature for 16 h, before being evaporated to dryness. The residue was dissolved in ethyl acetate and 0.5 M hydrochloric acid was added.The two layers were separated and the organic phase was washed with 0.5 M hydrochloric acid before being extracted with dilute aqueous sodium hydrogen carbonate solution.The aqueous extracts were washed with ethyl acetate, saturated with sodium chloride and acidified to pH 1.The product was extracted into ethyl acetate, and the organic solution was washed with brine, dried and evaporated to leave the product as a white foam 0.358 g, 38 max. CH2Cl2 3400, 1730, 1660, 1630, 1525, 1350, 1210 cm l n.m.r. showed signals from two isomers, d CDC13 1.14 3H, t, J 7Hz, CH2CH3 , 3.00 3.70 6H, m, 3 x NCH2 , 5.27 2H, s, aryl CH2 , 5.51 1H, m, a CH rotamers , 5.82 1H, br.s., exchangeable with D2O, NH , 7.12 1H, br.s., exchangeable with D2O,NH , 7.20 7.50 7H, m, aromatics and 8.17 2H, AA BB , J 9 Hz, aromatics Found m z positive xenon F.A.B. MH 473. C22H24N408 requires M 472 . Example 12Benzyl 6ss D 2 3 N ethyl N 4 nitrobenzyloxalyl amino ethylamino carbonylamino 2 phenylacetamidol 6a imethylthio penicillanate A solution of D 2 2 N ethyl N 4 nitrobenzyloxalyl amino ethylamino carbonylamino 2 phenylacetic acid 0.139 g, 0.29 mmol in dichloromethane 10 ml was added slowly with stirring to a solution of benzyl 6B amino 6a methylthio penicillanate 0.102 g, 0.29 mmol and N,N dicyclohexylcarbodiimide 0.066 g, 0.32 mmol in dichloromethane 10 ml , and the reaction mixture was stirred at room temperature for 16 h.The solution was evaporated to dryness and the residue was chromatographed on silica gel 60 eluting with hexane ethyl acetate 1 2 to afford the essentially pure title compound 0.024 g, 10 . T.l.c. and spectroscopic i.r, n.m.r. and m.s. data were identical to those of the material obtained by the method of example 1. Example 13 D 2 2 N Ethyl N 4 nitrobenzyloxalyl amino ethylamino carbonylamino 2 3,4 dihydroxyphenyl acetic acid D 3,4 Dihydroxyphenylglycine 0.915 g, 5 mmol in hexamethyldisilazane 7 ml containing chlorotrimethylsilane 0.7 ml was ref fluxed under argon for 6 h. The resulting solution was evaporated to dryness and the residue was dissolved in dichloromethane 10 ml and added to a solution of 4 nitrobenzyl N 2 isocyanatoethyl N ethylamino oxalate 5 mmol in dichloromethane 25 ml . The reaction solution was stirred for 16 h at room temperature before being evaporated to dryness. The residue was dissolved in a mixture of ethyl acetate and 0.5 M hydrochloric acid and stirred for 5 minutes at room temperature.The mixture was adjusted to pH 8, the two phases were separated and the aqueous phase was washed with ethyl acetate. It was then saturated with sodium chloride, adjusted to pH 1.5 with hydrochloric acid, and the product was extracted into 50 50 ethyl acetate tetrahydrofuran. The combined extracts were washed with brine, dried over magnesium sulphate, and evaporated to leave an oil 0.977 g .This was chromatographed on silica gel 60 eluting with ethyl acetate iso propanol water 10 6 1 to afford the product as a pale brown foam 0.56 g, 22 vmax. tetrahydrofuran 3300, 1740, 1665, 1525, 1350 cm n.m.r. shower ignals due to two isomers, 6 CD3 2SO 1.04 3H, ot J 7Hz, CH2CH3 , 3.02 3.42 6H, m, 3 x NCH2 4.78 1H, m, ArCH , 5.37 and 5.45 2H, 2s, aryl CH2 , 6.40 6.90 4H, m, aromatics and NH , 7.67, 7.70, 8.24, and 8.27 4H, AA BB , J 10.5 Hz, aromatics and 8.50 9.30 2H, br.s, NH and CO2H . Found m z positive xenonF.A.B. MH 505. C22H24N4o10 requires M 504 . Example 14 D 2 2 N Ethyl N 4 nitrobenzYloxalyl amino ethylamino carbonylamino 2 3,4 diacetoxyphenyl acetic acidThe 3,4 dihydroxy acid of example 13 0.252 g, 0.5 mmol in tetrahydrofuran 2 ml was treated with water 10 ml and the pH was adjusted to 7.5 with dilute aqueous sodium hydrogen carbonate solution. Acetic anhydride 0.112 g, 1.1 mmol was then added, and the pH re adjusted to 7.5. The reaction was allowed to proceed for 1.5 h at room temperature. T.l.c.indicated incomplete reaction so more acetic anhydride 0.112 g, 1.1 mmol was added and reaction was continued for a further hour. The solution was then washed with ethyl acetate, saturated with sodium chloride, and the pH adjusted to 1.5 with 1 M hydrochloric acid. The product was extracted into 50 50 tetrahydrofuran ethyl acetate, the extracts were washed with brine, dried over magnesium sulphate and then evaporated to dryness to afford the product 0.048 g, 16 vmax CH2C12 3390, 1765, 1730, 1660, 1530, 1370, 1350 cm 1 CD3OD 1.13 3H, t, J 7 Hz,NCH2CH3 , 2.22 6H, s, 2 x OCOCH3 , 3.10 3.60 6H, m, 3 x NCH2 , 5.10 5.50 3H, m, aryl CH2 and a CH rotar ters , 6.60 7.35 3H, m, aromatics , 7.59, 7.64, 8.21, and 8.25 4H, 2AA1BB , J 9Hz, aromatics, rotamers . Example 15Benzyl 6ss lD 2 l2 N ethyl N 4 nitrobenzyloxalol amino ethylamino carbonylamino 2 3,4 diacetoxy phenyl acetamido 6 alpha methylthio penicillanate A solution of D 2 2 N ethyl N 4 nitrobenzyl oxalyl amino ethylamino carbonylamino 2 3,4diacetoxyphenyl acetic acid 0.048 g1 0.08 mmol in dichloromethane 5 ml was added dropwise over 1.5 h to a stirred solution of benzyl 6B amino 6a methylthio penicillanate 0.028 g, 0.08 mmol and N,N1 dicyclohexylcarbodiimide 0.018 g, 0.088 mmol in dichloromethane 3 ml . The reaction mixture was stirred overnight at room temperature before being evaporated to dryness and chromatographed on silica gel 60 eluting with chloroform grading to 2 ethanol chloroform to afford the slightly impure product 0.009 g, 12 . T.l.c. and spectrosccopic i.r., n.m.r. and m.s. data were identical with those obtained from the compound of example 9. Example 16Benzyl 6ss 1D 2 ll2 lN ethyl N 2,2,2 trichloroethoxy carbonyl amino ethylaminolcarbonylamino 2 3,4 diacetoxyPhenyl acetamido 6 methylthio penicillanate Benzyl 6B lD 2 2,2,2 trichloroethoxycarbonylamino 2 3,4 diacetoxyphenyl acetamido 6a methylthio penicillanate 1.55 g, 2 mmol was dissolved in tetrahydrofuran 30 ml and 1M potassium dihydrogen phosphate 6 ml was added. The mixture was stirred vigorously, freshly acid washed zinc 3 g was added and the pH maintained in the region 3.0 4.0 by addition of hydrochloric acid, the reaction being monitored by t.l.c. After 1 h a further portion of zinc 3 g was added the reaction appeared complete by t.l.c. in a further 1 h.The insoluble material was filtered off and washed well with water and ethyl acetate the organic phase was separated and washed further with water 2 x 50 ml and brine, then dried over anhydrous magnesium sulphate and evaporated to dryness. The residue was redissolved in anhydrous dichloromethane 10 ml and stirred at OOC with exclusion of moisture. To this was added over 2 min.a solution of 2 N ethyl N 2,2,2 trichloroethoxy carbonyl amino ethyl isocyanate in the same solvent 10 ml prepared from the corresponding amine hydrochloride 2 mmol as described in Example 7. The resulting solution was allowed to regain room temperature, then stirred for a further 1 h and concentrated to near dryness. Workup for a neutral fraction as described in Example 6 was followed by chromatography on silica gel 30 g , eluting with ethyl acetate hexane, 1 1.Appropriate fractions were combined and evaporated to give the title compound 0.92 g, 52 RF 0.38 in 5 methanol chloroform max. K Br 1777, 1745, 1714, 1641, 1544, 1499 cm l CD3 2C0 1.15 6H, s t, CH3CH2N one 2 CH3 , 1.25 3H, s, 2 CH3 , 2.24, 2.26 6H, 2s, 2 x CH3C0 , 2.32 3H, s, CH3S , 3.20 3.50 6H, m, 3 x CH2N , 4.41 1H, s, 3 H , 4.79, 4.83 2H, ABq, OCH2CC13 , 5.21 2H, s, PhCH20 , 5.41 1 H, s, 5 H , 5.65 1H, d, s on D20 exchange, CHNH , 6.00 1 H, br m,D20 exchanged, NH , 6.47 1H, approx. t, D20 exchanged,NH , 7.10 7.50 8H, m, Ar H , 8.84 1 H, br s,D20 exchanged, 6 NH Found MH , 890 C36H42C13N5011S2 requires M 889 . Example 17Benzyl 6 D 2 4 ethyl 2,3 dioxopiperazin i yl carbonylaminol 2 3,4 diacetoxyphenyl acetamido 6ff methylthio penicillanate i Benzyl 6ss D 2 2 N ethyl N methyloxalyl amino ethylaminoacarbonylaminol 2 3,4 diacetoxyphenyl acetamido 6a methyIthio penicillanate Benzyl 66 D 2 2 N ethyl N 2,2,2 trichloroethoxy carbonyl amino ethylamino carbonylamino 2 3,4 diacet oxyphenyl acetamido 6a methylthio penicillanate 450 mg, 0.5 mmol was dissolved in tetrahydrofuran 20 ml and 1 M potassium dihydrogen phosphate 4 ml was added. Freshly acid washed zinc 1 g was added to the vigorously stirred mixture and the pH was maintained at about 3.5 4.0 by addition of hydrochloric acid.Further portions of zinc 2 x 1 g were added after 1.5 h and 2 h, and after 2.5 h the reaction appeared complete by t.l.c. The mixture was filtered and the solids were washed with water and tetrahydrofuran, then the aqueous phase was saturated with sodium chloride and the organic phase was separated. The aqueous phase was extracted once more with tetrahydrofuran, then the total organic extract was dried over magnesium sulphate and rigorously evaporated to dryness.Without further purification, this material was redissolved in anhydrous dichloromethane 10 ml , cooled to OOC and stirred under argon with triethylamine 0.14 ml, 1 mmol . Methyl oxalyl chloride 0.06 ml, 0.65 mmol was added and the reaction was monitored by t.l.c. After 0.25 h the reaction mixture was worked up for a neutral product as described in Example 6.Chromatography on silica gel 15 g , eluting firstly with ethyl acetate hexane 2 1, then with ethyl acetate, gave on evaporation of appropriate fractions the title product 235 mg, 59 RF 0.53 in 10 methanol chloroform max. KBr 1777, 1743, 1653, 1541, 1500 cm 6 CD3 2C0 1.15, 1.26 6H, 2s, CH3 2C , 1.14 3H, m, CH3CH2N rotamers , 2.24, 2.26 6H, 2s, 2 x CH3C0 , 2.32 3H, s, CH3S , 3.20 3.50 6H, m, 3 x CH2N , 3.75 and 3.83 3H, 2s, CH302C rotamers , 4.41 1H, s, 3 H , 5.21 2H, s, PhCH20 , 5.65 1H, d,CHNH , 6.00 1H, approx. t, D20 exchanged, NHCH2 , 6.50 1H, approx. t, D20 exchanged, NHCH rotamers , 7.10 7.50 8H, m, Ar H , 8.80 1H, brs, D20 exchanged, 6 NH Found MH , 802. C36H43N5012S2 requires M 801 . ii Benzyl 6B D 2 4 ethyl 2,3 dioxopiperazin 1 yl carbonylamino 2 3,4 diacetoxyphenyl acetamido 6a methylthio penicillanateBenzyl 6ss D 2 2 N ethyl N methyloxalyl amino ethylamino carbonylamino 2 3,4 diacetoxyphenyl acetamido 6a methylthio penicillanate 46 mg, 0.057 mmol was dissolved in dry dichloromethane 1 ml and treated at ambient temperature with a 0.1 M solution of 1,8 diazabicyclo 5.4.0 undec 7 ene in the same solvent 0.6 ml . After 10 min. little starting material was visible on t.l.c. the solution was diluted with ethyl acetate 20 ml and worked up for a neutral product as in Example 6.Chromatography on silica gel 2.5 g , eluting firstly with ethyl acetate hexane 2 1, then ethyl acetate, gave on evaporation of appropriate fractions the title compound 23 mg, 52 , with spectral characteristics identical to those given in Example 10. Example 18Benzyl 6ss D 2 2 N ethyl N methyloxalyl amino ethylaminolcarbonylamino 2 3,4 diacetoxyphenyl acetamido 6 a formamidopenicillanate Benzyl 6ss D 2 2 N ethyl N methyloxalyl amino ethylamino carbonylamino 2 3,4 diacetoxyphenyl acetamido 6 a methylthio penicillanate 160 mg, 0.20 mmol in anhydrous dimethylformamide 3 ml was stirred at 400C under argon. Mercury II acetate 64 mg, 0.20 mmol was added, followed by a solution of ammonia 3.5 mg, 0.20 mmol in dimethylformamide 0.16 ml . The mixture was allowed to regain ambient temperature after 0.75 h no starting material was visible on t.l.c.After 1 h the mixture was partitioned between ethyl acetate 20 ml and water 20 ml the organic phase was separated and washed further with water 4 x 20 ml and brine, then dried over magnesium sulphate and evaporated to dryness.Without further purification this intermediate was redissolved in anhydrous dichloromethane 3 ml and stirred at OOC anhydrous pyridine 0.2 ml, 2.48 mmol was added, followed by acetic formic anhydride 0.10 ml, 1.24 mmol . The solution was allowed to regain ambient temperature, then poured into ethyl acetate 20 ml and washed sequentially with 0.5 M hydrochloric acid 2 x 10 ml , saturated aqueous sodium hydrogen carbonate 2 x 10 ml , water and brine. The final organic phase was dried over anhydrous magnesium sulphate, then evaporated to a crude product 150 mg which was purified by chromatography on silica gel, eluting firstly with 2 methanol in chloroform, then 3 , and finally 4 . Product rich fractions were combined and evaporated to give the title compound 102 mg, 64 RF0.41 in 10 methanolchloroform max. KBr 1772, 1743, 1653 br, 1544, 1499 cm 1 6 CD3 2C0 1.05, 1.23 6H, 2s, CH3 2C , 1.10, 1.14 3H, 2t, CH3CH2N, rotamers , 2.24, 2.26 6H, 2s, 2 x CH3C0 , 3.20 3.50 6H, m, 3 x CH2N , 3.74, 3.83 3H, 2s, CH302C rotamers , 4.40 1H, S, 3 H , 5.19 2H, s, PhCH2O , 5.58 1H, s, 5 H , 5.61 1H, approx d, s on D20 exchange, CHNH , 6.01 1H, br s,D20 exchanged, NH , 6.40 6.60 1H, m, D20 exchanged,NHCH , 7.10 7.50 8H, m, ArH , 8.10 8.20 2H, m, approx. s on D20 exchange, NHCH0 , 8.79 1H, br s,D20 exchanged, 6 NH , Found M H, 797. C36H42N6013S requires M, 798 . Example 19Sodium 6ss D 2 2 N ethyl N methyloxalyl amino ethylamino carbonylaminol 2 l3,4 diacetoxyphenyl acetamido 6a formamidopenicillanate Benzyl 6ss D 2 2 N ethyl N methyloxalyl amino ethylamino carbonylamino 2 3,4 diacetoxyphenyl acetamido 6a formamidopenicillanate 92 mg, 0.12 mmol was dissolved in tetrahydrofuran 10 ml . 10 Palladium on charcoal 100 mg was added and the mixture was hydrogenated under ambient conditions after 1.75 h no starting material was visible by t.l.c.The catalyst was filtered and well washed with tetrahydrofuran, and the filtrate was evaporated to dryness.The residue was redissolved in acetone 2 ml and treated with a solution of sodium 2 ethylhexanoate in 4 methylpentan 2 one 1 equivalent . Precipitation was completed by diluting to 15 ml with ether the white precipitate was filtered, washed with acetone ether 1 1 and ether and dried to give the title penicillin 68 mg, 81 RF0.26 in n butanol acetic acid water, 4 1 1 max. KBr 1771, 1653 br, 1610 sh, 1553, 1500 cm 6 D20 0.95, 1.29 6H, 2s, CH3 2C , 1.14, 1.15 3H, 2t, CH3CH2N rotamers , 2.33,2.34 6H, 2s, 2 x CH3C0 , 3.15 3.65 6H, m, 3 x CH2N , 3.78, 3.89 3H, 2s, CH3O2C rotamers , 4.18 1H, s, 3 H , 5.34 1H, s, CHNH , 5.59 1H, s, 5 H , 7.25 7.55 3H, m, ArH , 8.13 lH, s, NHCNO Found MH , 731. C29H35N6Na013S requires M, 730 . Example 20 t Butyl 7B D 2 2 N ethyl N 4 nitrobenzYloxalyl amino ethylamino carbonylamino 2 phenylacetamido 7 a formamidocephalosporanate A solution of t Butyl 7ss D 2 azido 2 phenylacetamido 7a formamidocephalosporanate 0.267 g, 0.5 mmol and ammonium chloride 0.178 g, 3.3 mmol in methanol 8 ml and tetrahydrofuran 4 ml was treated with freshly acid washed zinc powder 0.1 g , and the reaction mixture was stirred at room temperature for 0.5 h. More zinc 0.2 g was then added and stirring at room temperature continued for a further 5 minutes. The reaction mixture was filtered and the filtrate was evaporated to dryness.The residue was dissolved in dichloromethane, dried over magnesium sulphate, and then the solution was evaporated to dryness to leave the crude t butyl 7ss D 2 amino 2 phenylacetamido 7a formamidocephalo sporanate. This was dissolved in dichloromethane 5 ml and added dropwise to a solution of 4 nitro benzyl N 2 isocyanatoethyl N ethylamino oxalate 0.5 mmol in dichloromethane 10 ml at OOC. The reaction solution was stirred at 0 C for 0.5 h and then for 1 h at room temperature before being washed with 0.5 M hydrochloric acid and brine.The solution was dried over magnesium sulphate, evaporated to dryness and the residue chromatographed on silica gel 60 eluting with chloroform grading to 5 ethanol chloroform to afford the desired product 0.075 g, 18 Vmax. CH2C12 3375, 1790, 1745, 1690, 1655, 1530, 1350, 1210 cm n.m.r. showed signals from two isomers, 6 CDC13 1.09 3H,2t, CH2CH3 , 1.50 9H, s, t butyl , 2.06 3H, s, OCOCH3 , 2.99 and 3.01 1H, half of ABq, J 18Hz, 2 H , 3.15 3.70 7H, m, 3 x CH2N and 2 H , 4.78 and 4.95 2H, ABq, J 13Hz, CH20Ac ,5.13 and 5.19 2H, ABq, J 12Hz, CH2Ar , 5.28 and 5.30 1H, 2s, 6 H , 5.79 1H, m, PhCHNH isomers , 5.99 1H, m, CH2NHC0 isomers , 7.70 1H, m, PhCHNH isomers , 7.10 7.60 7H, m, aromatics , 7.98 and 8.02 1H, 2s, CHO isomers , 8.18 2H, half ofAA BB , J 9Hz, aromatics , 8.39 1H, br.s, NHCHO and 8.67 1H, m, 7B NH isomers . Found m z positive xenon F.A.B. MH 826. C37H43N7013S requires M 825 . Example 21 t Butyl 7ss D 2 4 ethyl 2,3 dioxopiperazin 1 yl carbonylamino 2 phenylacetamido 7 alpha formamidocephalo sporanate i t Butyl 7ss D 2 4 ethyl 2,3 dioxopiperazin 1 yl carbonylamino 2 phenylacetamido 7 alpha formamido 3 acetoxymethyl ceph 2 em 4 carboxylateA solution of t butyl 7ss D 2 2 N ethyl N 4 nitrobenzyloxalyl amino ethylamino carbonylamino 2 phenylacetamido 7 alpha formamidocephalosporanate 0.052g, 0.063 mmol in dichloromethane 12 ml was treated with a 1M solution of 1,8 diazabicyclo 5.4.0 undec 7 ene in dichloromethane 0.630 ml, 0.063 mmol and the reaction solution was stirred at room temperature for 0.25 h.It was then washed with 0.5 M hydrochloric acid and brine, and then dried over magnesium sulphate before being evaporated to dryness.The crude product was chromatographed on silica gel 60 eluting with 5 ethanol chloroform to afford the title compound 0.018 g, 42 max. CH2Cl2 3280, 1790, 1740 sh, 1720, 1690, 1495, 1360 cm 1 n.m.r. showed mainly the title compound plus 10 3 isomer, 6 CDC13 1.23 3H, t, J 7Hz, CH2CH3 , 1.50 9H, s, t butyl , 2.05 3H, s, OCOCH3 , 3.54 3H, m, CH2CH3 and piperazine CH , 3.72 1H, m, piperazine CH , 3.93 1H, m, piperazine CH , 4.13 lH, m, piperazine CH , 4.49 and 4.60 2H, ABq, J 13Hz, CH20Ac , 4.83 1H, s, 4 H , 5.40 1H, s, 6 H , 5.54 1H, d, J 7Hz, NHCHO , 6.02 1H, s, 2 H , 7.18 7.53 5H, m, aromatics , 7.90 1H, s, NHCO , 8.12 1H, s, CHO , 8.32 1H, br.s,NHCO , and 9.98 1H, d, J 7Hz, NHCHO , Found m z positive xenon F.A.B. MH , 673. C30H36N6 10S requiresM, 672 ii t Butyl 7B D 2 1 4 ethyl 2,3 dioxopiperazin l yl carbonylamino 2 phenylacetamido 7 alpha formamidocephalosporanate l oxideA solution of t butyl 76 D 2 4 ethyl 2,3 dioxo piperazin 1 yl carbonylamino 2 phenylacetamido 7 alpha formamido 3 acetoxymethyl ceph 2 em 4 carboxylate 0.017 g, 0.025 mmol in dichloromethane 2 ml was treated with a solution of 3 chloroperoxybenzoic acid 0.0047 g, 0.0275 mmol in dichloromethane 1 ml .The reaction solution was stirred at room temperature for 0.75 h, and then more 3 chloroperoxybenzoic acid 0.0023 g in dichloromethane 0.5 ml was added.After stirring for a further 0.25 h the solution was diluted with dichloromethane and washed with dilute sodium hydrogen carbonate solution and brine. It was dried over magnesium sulphate, filtered and evaporated to leave the crude product, which was chromatographed on silica gel 60 eluting with ethyl acetate grading to 5 ethanol ethyl acetate to afford the two sulphoxide isomers.The less polar isomer 0.008 g, 47 had max. CH2C12 3260, 1800, 1740 sh, 1720, 1690, 1680 sh 1500, 1220, 1040 cm l 6 CD3 2CO 1.18 3H, t, J 7Hz,CH2CH , 1.54 9H, s, t butyl , 2.00 s, OCOCH3, obscured by CD3COCHD2 , 3.52 2H, q, J 7Hz, CH2CH3 , 3.57 3.79 4H, m, piperazine CH2 and 2 H2 , 4.05 2H, m, piperazine CH2 , 4.58 and 4.67 1H, 2 x half of ABq, J 13Hz, CHOCOCH3 rotamers , 4.93 and 5.03 1H, 2s, 6 H rotamers , 5.13 and 5.25 1H, 2 x half of ABq, J 13Hz, CHOCOCH3 rotamers , 5.70 1H, d, J 7Hz, PhCHNH , 7.34 3H, m, aromatics , 7.53 2H, m, aromatics , 8.17 0.75H, s,NHCHO rotamer , 8.42 lH, s, 7ss NH , 8.54 0.25H, a, J 11Hz, NHCHO rotamer , 8.93 and 9.25 1H, 2s, NHCHO rotamers and 9.96 1H, d, J 7Hz, PhCHNH . Found m z positive xenonF.A.B. with NH4SCN MNH4 , 706. C30H36N6O11S requiresM, 688 . The more polar isomer 0.007g, 41 had max. CH2Cl2 3260 1800, 1735 sh, 1715, 1690, 1500, 1220, 1040 cm 1 CD3 3CO 1.17 3H, t, J 7Hz, CH2CH3 , 1.52 9H, s, t butyl , 2.07 s, OCOCH3, obscured by CD3COCHD2 , 3.51 2H,,q, J 7Hz, CH2CH3 , 3.57 and 3.83 2H, ABq,J 16Hz, 2 H2 , 3.72 2H, m, piperazine CH2 , 4.08 2H, m, piperazine CH2 , 4.75 1H, s, 6 H , 4.78 and 5.21 2H, ABq, J 13Hz, CH2OCOCH3 , 5.73 1H, d, J 7Hz,PhCHNH , 7.40 3H, m, aromatics , 7.54 2H, m, aromatics , 8.27 1H, s, NHCHO , 8.85 1H, s, NHCO , 9.00 1H, s, NHCO , and 9.96 1H, d, J 7Hz, PhCHNH . Found m z positive xenon F.A.B. with NH4SCN MNH4 , 706. C30H36N6O11S requires M, 688 . iii t Butyl 7ss D 2 4 ethyl 2,3 dioxopiperazin 1 yl carbonylamino 2 phenylacetamido 7 alpha formamidocephalosporanateThe corresponding sulphoxide 0.100g, 0.145 mmol in dichloromethane 10 ml was cooled to 0 C and then treated with a solution of phosphorous trichloride 0.059g, 0.434 mmol in dichloromethane 1 ml . The reaction solution was stirred at 0 C for 1.25 h and then diluted with ethyl acetate. The solution was washed with dilute sodium hydrogen carbonate and brine, before being dried over magnesium sulphate and evaporated to dryness.The crude product was chromatographed on silica gel 60 eluting with ethyl acetate grading to 5 ethanol ethyl acetate to afford the title compound 0.035g, 36 from the more polar sulphoxide isomer 0.023g, 23 from the less polar sulphoxide isomer max. CH2C12 3270, 1790, 1740 sh, 1720, 1690, 1495, 1220 cm1 6 CD3 2CO 1.17 3H, t, J 7Hz, CH2CH3 , 1.51 9H, s, t butyl , 2.01 3H, S, OCOCH3 , 3.16 and 3.49 2H, ABq, J 17Hz, 2 H2 , 3.51 2H, q, J 7Hz,CH2CH3 , 3.70 2H, m, piperazine CH2 , 4.03 2H, m, piperazine CH2 , 4.70 and 4.98 2H, ABq, J 13Hz,CH2OCOCH3 , 5.18 1H, s, 6 H , 5.73 1H, d, J 7 Hz,PhCHNH , 7.35 3H, m, aromatics , 7.57 2H, m, aromatics , 8.20 lH, s, NHCHO , 8.40 1H, s, NHCO , 8.71 1H, s, NHCO and 9.99 1H, d, J 7Hz, PhCHNH . found m z positive xenon F.A.B with NH4SCN MNH4 , 690. C30H36N6O10S requires M, 672 . Example 22 t Butyl 7ss D 2 4 ethyl 2,3 dioxopiperazin 1 yl carbonslamino 2 phenslacetamido 7a formamido 3 acetoxymethyl ceph 2 em 4 carboxylateIn addition to the use of l,8 diazabicyclo 5.4.0 undec 7 ene in dichloromethane as in example 21, t butyl 7ss D 2 2 N ethyl N 4 nitrobenzyloxalyl amino ethylamino carbonylamino 2 phenylacetamido 72 formamidocephalosporanate has been cyclised to the title compound under the following conditions a Triethylamine in dichloromethane 1 day at room temperature b Pyridine plus 4 dimethylamino pyridine in dichloromethane 10 days at room temperature.c N Methylmorpholine in dichloromethane 17 days at room temperature.d N,N di isopropylethyiamine in dichioronethane 6 days at room temperature.e Morpholine in dichloromethane 5 days at room temperature. Example 23 a D 2 2 N Ethyl N ethyloxalyl amino ethylamino carbonylamino 2 3, 4 dihydroxy phenyl acetic acid A solution of 2 N ethyl N ethyloxalyl aminoZethyl ammonium chloride 6.4g, 28.5 mmole in M.D.C. 200 ml was cooled to 10 . To this solution was added a solution of phosgene in toluene 39 ml of a 12.5 w w solution followed by a solution of triethylamine 8.55 g, 85 mmol in M.D.C. 25 ml at the same temperature. Stirring was continued for 20 mins during which time precipitation occurred. This mixture was cooled to 15 and reserved. 3,4 dihydroxyphenyl glycine 5.2 g, 28.5 mmol was suspended in hexamethyldisilazane 80 ml and tri methylchlorosilane 1 ml and ref fluxed for 30 minutes. The solution was cooled and stirred in vacuo and redissolved in M.D.C. 20 ml . This solution was added to the mixture prepared earlier over 15 minutes and the total then stirred to room temperature. The mixture was stripped to low volume and partitioned between ethyl acetate and 2M hydrochloric acid 100 50 ml and the aqueous rejected. The solution was washed with water 3 x 50 ml and extracted with sodium bicarbonate solution. The aqueous was washed with ethyl acetate and then covered with 1 1 THF ethyl acetate 50 ml 50 ml , saturated with sodium chloride and the pH adjusted to 1 with conc.hydrochloric acid. The organic layer was washed with brine and stripped in vacuo to afford the title compound as a white foam 6.0 g, 15.1 mmol, 53 . b D 2 L 2 iN Ethyl N e thyloxalyl amino e thylamino carbonylamino 2 3,4 diacetoxy phenyl acetic aThe corresponding 3,4 dihydroxy acid 5.5 g, 13.8 mmol in 1 1 THF water 140 ml was brought to pH 7 with aqueous sodium carbonate solution. Acetic anhydride 20 ml was added and the pH left at 6.5 7.0 with sodium carbamate solution. When the pH steadied ca 20 min a further 20 ml acetic anhydride was added the process repeated. The final solution at pH 7.5 was stripped to remove THF and washed with ethyl acetate. The aqueous phase was covered with ethyl acetate 100 ml and the pH adjusted to 1 with conc. hydrochloric acid. The organic phase was washed with brine 50 ml , dried, and stripped to an oil. This oil was triturated with hexane to remove acetic acid and the resultant oil dried in vacuo to afford an off white foam 5.5 g, 11.4 mmol,Example 24 D 2 lt2 lN Ethyl N methyloxalyl aminoJethylamino carbonylamino 2 3,4 dihydroxy phenyl acetic acid This compound was prepared from 2 N ethyl N methyloxalyl amino ethyl ammonium chloride by the method described in Example 23. Example 25D 2 2 N Ethyl N t butyloxalyl amino 2 3,4 dihydr phenyl acetic acidThis compound was prepared from 2 N ethyl N t butyloxalyl amino ethyl ammonium chloride by the method described inExample 23.